Position in KYMR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$115,561,787
+$30,285,155 QoQ
Shares Held
1,007,777
-1.6% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#17
of 275 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. KYMR ranks #18 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in KYMR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,561,787 | 1,007,777 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $85,276,632 | 1,023,852 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $57,348,458 | 737,032 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $36,717,437 | 648,718 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $24,339,510 | 557,734 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,246,995 | 593,606 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $18,901,743 | 469,842 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,299,905 | 217,619 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,277,484 | 210,301 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,926,535 | 296,680 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,649,787 | 300,463 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,262,350 | 162,759 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $5,534,060 | 240,716 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,490,290 | 185,295 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,060,914 | 202,761 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,081,641 | 49,685 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,194,824 | 111,469 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $5,759,328 | 136,090 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,388,174 | 69,116 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $777,893 | 13,243 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,287,190 | 26,540 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $988,675 | 25,442 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $224,006 | 3,613 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $7,463 | 231 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||